Business
Propanc Biopharma Implements Reverse Stock Split to Meet Nasdaq Standards
The biopharmaceutical company aims to restore compliance with Nasdaq's minimum bid price requirement ahead of planned clinical studies.
Biopharmaceutical
1 story about this topic.